Analyzing how coronaviruses interact with hosts and adapt

Project 2 - Ex Vivo Analysis of Coronavirus Tropism, Adaptation, Replication, and Host Response

['FUNDING_OTHER'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11005782

This study is looking at how coronaviruses, like the one that causes COVID-19, interact with human and bat cells to learn how they adapt and spread, with the hope of finding new ways to treat COVID-19 and similar infections.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-11005782 on ClinicalTrials.gov

What this research studies

This research investigates the interactions between coronaviruses, such as SARS-CoV-2, and their hosts to understand how these viruses adapt and replicate. By using advanced techniques like proteomics, transcriptomics, and epigenomics, researchers will analyze virus-host interactions in human and bat cells. The goal is to identify key proteins and pathways that influence disease severity and could lead to the development of new antiviral therapies. Patients may benefit from insights gained that could improve treatment options for COVID-19 and related infections.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have been infected with SARS-CoV-2 or are at risk of severe COVID-19 outcomes.

Not a fit: Patients who have not been infected with coronaviruses or those with unrelated respiratory conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antiviral therapies for COVID-19 and other coronavirus infections.

How similar studies have performed: Other research has shown success in understanding virus-host interactions, making this approach promising for developing new treatments.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: after COVID-19 infection, after infection by SARS-CoV-2, after SARS-CoV-2 infection, after SARS-CoV2 infection, after severe acute respiratory distress syndrome CoV-2 infection

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.